(2541466), M. Q., (15010), P. M., (104852), Y. Z., (95017), H. J., (22686257), L. G., (8495742), G. L., . . . (8665254), J. G. (2025). Table 1_Immune checkpoint inhibitor therapy in advanced cancer: Clinical association of irAEs type, inflammatory markers and efficacy.docx.
Chicago Style (17th ed.) Citation(2541466), Mengying Qian, Ping Ma (15010), Yu Zhao (104852), Hao Jiang (95017), LiYang Gao (22686257), Gaoyang Lin (8495742), Difan Duan (22686260), and Jinmin Guo (8665254). Table 1_Immune Checkpoint Inhibitor Therapy in Advanced Cancer: Clinical Association of IrAEs Type, Inflammatory Markers and Efficacy.docx. 2025.
MLA (9th ed.) Citation(2541466), Mengying Qian, et al. Table 1_Immune Checkpoint Inhibitor Therapy in Advanced Cancer: Clinical Association of IrAEs Type, Inflammatory Markers and Efficacy.docx. 2025.